「Prinaberel」の版間の差分
bsd>Ffffrr (Importing Wikidata short description: "Chemical compound" (Shortdesc helper)) |
細 (1版 をインポートしました) |
(相違点なし)
| |
2025年3月18日 (火) 19:33時点における最新版
| ファイル:Prinaberel.svg | |
|---|---|
| Systematic (IUPAC) name | |
| (4Z)-2-Fluoro-4-(5-hydroxy-7-vinyl-1,3-benzoxazol-2(3H)-ylidene)-2,5-cyclohexadien-1-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 524684-52-4 |
| ATC code | None |
| PubChem | CID 5326893 |
| ChemSpider | 4484184 |
| UNII | A9C8MNF7CA 
|
| Chemical data | |
| Formula | C15H10FNO3 |
| SMILES | eMolecules & PubChem |
| |
Prinaberel (INN, USAN) (developmental code names ERB-041, WAY-202041) is a synthetic, nonsteroidal, and highly selective agonist of the ERβ subtype of the estrogen receptor.[1] It is used in scientific research to elucidate the role of the ERβ receptor.[2] Studies have indicated that selective ERβ agonists like prinaberel could be useful in the clinical treatment of a variety of medical conditions including inflammatory bowel disease, rheumatoid arthritis, endometriosis, and sepsis.[3] Accordingly, prinaberel either was or still is under investigation by Wyeth for the treatment of some of these conditions.[4]
See also
References
- ↑ Harris HA, Albert LM, Leathurby Y, et al. (October 2003). "Evaluation of an estrogen receptor-beta agonist in animal models of human disease". Endocrinology. 144 (10): 4241–9. doi:10.1210/en.2003-0550. PMID 14500559.
- ↑ Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA (May 2005). "Reflections on the discovery and significance of estrogen receptor beta". Endocrine Reviews. 26 (3): 465–78. doi:10.1210/er.2004-0027. PMID 15857973.
- ↑ Harris HA (2006). "Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential". Ernst Schering Foundation Symposium Proceedings. 2006/1 (1): 149–61. doi:10.1007/2789_2006_021. ISBN 978-3-540-49547-5. PMID 17824176.
- ↑ "Prinaberel - Wyeth phase change II, USA (endometriosis)". R & D Focus Drug News. 2006-06-05. Archived from the original on 2016-03-07. Retrieved 2012-05-20.
External links
| ||